Christopher Hutchins, MD
Orthopaedic Surgery · Westerly, RINPI 1902805591
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $72,000 of the $74,673 with a category attached, or 96.4%. Exactech, Inc. accounts for 96.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $72,504 and has fallen 98.1% since, to $1,387 in 2024. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $3111.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$72K
- Encore Medical, LP$1K
- Stryker$603
- Pacira Therapeutics, Inc.$125
- Sanofi-aventis U.S. LLC$102
- Heron Therapeutics, Inc.$89
- plus $165 from 2 others
What the payments were for
- Royalty or licence$810%
- Speaking & faculty fees$72,00096%
- Travel & lodging$9161%
- Food & beverage$1,6752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 3 | $72,312 |
| Encore Medical, LP | 10 | $1,277 |
| Stryker | 6 | $603 |
| Pacira Therapeutics, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $102 |
| Heron Therapeutics, Inc. | 1 | $89 |
| Johnson & Johnson | 1 | $83 |
| AstraZeneca | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$74,673 in reported general payments places this provider in the 90th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 37 | $605 |
| Oxycodone Hcl | 66 | $300 |
| Meloxicam | 103 | $284 |
| Tramadol Hcl | 67 | $139 |
| Mupirocin | 18 | $139 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Westerly
- Mouhanad El OthmaniWesterly$20K
- Anthony BuonannoJohnston$2M
- Alan DanielsEast Providence$1.9M
- Robert MarchandWakefield$1.4M
- Michael BradleyWakefield$1.4M
- Edward PaxtonProvidence$244K
- Valentin AntociEast Providence$210K
- Dominic KleinhenzEast Providence$164K
- Bassel DieboEast Providence$138K
- Steven BokshanProvidence$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.